| | | | | |
DV DoubleVerify Holdings, Inc. | €9,0185 | -0,36 % | €1,36B | €3,53M | |
PVLA Palvella Therapeutics, Inc. Common Stock | €98,6002 | +0,30 % | €1,36B | €334,49K | |
ATEX Anterix Inc. Common Stock | €65,0323 | -5,87 % | €1,36B | €699,37K | |
FTRE Fortrea Holdings Inc. Common Stock | €13,3626 | -0,07 % | €1,36B | €2,62M | |
ALNT Allient Inc. Common Stock | €83,9023 | +2,60 % | €1,35B | €264,33K | |
| €43,0814 | +1,33 % | €1,35B | €176,16K | |
RUM Rumble Inc. Class A Common Stock | €6,3889 | +0,41 % | €1,35B | €10,01M | |
ECAT BlackRock ESG Capital Allocation Term Trust | €13,4411 | +0,85 % | €1,34B | €295,78K | |
AVAH Aveanna Healthcare Holdings Inc. Common Stock | €6,7904 | +3,18 % | €1,34B | €2,47M | |
| €33,5393 | +2,15 % | €1,34B | €698,43K | |
CRML Critical Metals Corp. Ordinary Shares | €8,8589 | +0,79 % | €1,34B | €3,47M | |
GLUE Monte Rosa Therapeutics, Inc. Common Stock | €15,9679 | -0,63 % | €1,34B | €2,18M | |
LKFN Lakeland Financial Corp | €52,2545 | -0,37 % | €1,34B | €377,04K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,0435 | +4,00 % | €1,34B | €12,84M | |
| €8,0734 | -2,63 % | €1,34B | €4,34M | |
